Nasdaq Nari News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq nari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Nari Today - Breaking & Trending Today

Inari Medical (NASDAQ:NARI) PT Lowered to $57.00

Inari Medical (NASDAQ:NARI – Free Report) had its price objective trimmed by Needham & Company LLC from $72.00 to $57.00 in a research note released on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently commented on NARI. Truist Financial decreased their target price on shares […] ....

United States , Piper Sandler , William Hoffman , Mitchc Hill , Handelsinvest Investeringsforvaltning , Fifth Third Bancorp , Benjaminf Edwards Company Inc , Securities Exchange Commission , Inari Medical Inc , Third Bancorp , Needham Company , Nisa Investment Advisors , Canaccord Genuity Group , Inari Medical , Free Report , Genuity Group , Moderate Buy , Get Free Report , Director William Hoffman , Exchange Commission , Management Fondsmaeglerselskab , Investment Advisors , Inari Medical Daily , Nasdaq Nari , Lower Price Target , Needham Company Llc ,

Inari Medical (NASDAQ:NARI) PT Lowered to $57.00 at Needham & Company LLC

Inari Medical (NASDAQ:NARI – Free Report) had its price objective cut by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. NARI has been the topic of a number of other reports. Piper Sandler downgraded shares of Inari […] ....

United States , William Hoffman , Handelsinvest Investeringsforvaltning , Piper Sandler , Mitchc Hill , Canaccord Genuity Group , Securities Exchange Commission , Needham Company , Benjaminf Edwards Company Inc , Nisa Investment Advisors , Fifth Third Bancorp , Third Bancorp , Inari Medical Inc , Inari Medical , Free Report , Moderate Buy , Get Free Report , Director William Hoffman , Exchange Commission , Management Fondsmaeglerselskab , Investment Advisors , Inari Medical Daily , Nasdaq Nari , Lower Price Target , Needham Company Llc ,

Inari Medical (NASDAQ:NARI) Given New $57.00 Price Target at Needham & Company LLC

Inari Medical (NASDAQ:NARI – Free Report) had its price target lowered by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. NARI has been the subject of several other research reports. Piper Sandler lowered Inari Medical […] ....

United States , Mitchc Hill , Handelsinvest Investeringsforvaltning , William Hoffman , Piper Sandler , Nisa Investment Advisors , Needham Company , Inari Medical Inc , Benjaminf Edwards Company Inc , Fifth Third Bancorp , Canaccord Genuity Group , Securities Exchange Commission , Third Bancorp , Inari Medical , Free Report , Genuity Group , Truist Financial , Moderate Buy , Get Free Report , Director William Hoffman , Exchange Commission , Management Fondsmaeglerselskab , Investment Advisors , Inari Medical Daily , Nasdaq Nari , Lower Price Target ,

Inari Medical (NARI) Scheduled to Post Earnings on Tuesday

Inari Medical (NASDAQ:NARI – Get Free Report) will release its earnings data after the market closes on Tuesday, April 30th. Analysts expect Inari Medical to post earnings of ($0.16) per share for the quarter. Inari Medical has set its FY 2024 guidance at EPS.Investors that are interested in participating in the company’s conference call can […] ....

United States , William Hoffman , Mitchc Hill , Piper Sandler , Needham Company , Inari Medical Inc , Securities Exchange Commission , Canaccord Genuity Group , Inari Medical , Get Free Report , Director William Hoffman , Exchange Commission , Genuity Group , Inari Medical Daily , Nasdaq Nari ,

Inari Medical Announces the Release of 2023 Ethos and

IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and. ....

John Hsu , Inari Medical Inc , Sustainability Report , Drew Hykes , Inari Medical , Nasdaq Nari , Inari Medical ,